Evidence map›Paper›PMID 41874822›Full record

ArticleMolecular imaging and biology2026

Astrocyte Activation Persists after Recovery of Myelin and Motor Deficits in the Cuprizone Model: a Longitudinal PET and CNS Tissue Analysis Study.

V Pegoretti, A S Boerema, J W A Sijbesma, L E R Dietz, N Alberts, W Douwenga, U L M Eisel, E F J de Vries

Abstract read
In one paragraph

Article in Molecular imaging and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

V Pegoretti *Department of Molecular Neurobiology, Groningen Institute of Evolutionary Life Science (GELIFES), University of Groningen, Groningen, The Netherlands.ORCID 0000-0003-1148-4541
A S Boerema *Department of Molecular Neurobiology, Groningen Institute of Evolutionary Life Science (GELIFES), University of Groningen, Groningen, The Netherlands. ate.boerema@hvhl.nl.
J W A SijbesmaDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
L E R DietzDepartment of Molecular Neurobiology, Groningen Institute of Evolutionary Life Science (GELIFES), University of Groningen, Groningen, The Netherlands.
N AlbertsDepartment of Molecular Neurobiology, Groningen Institute of Evolutionary Life Science (GELIFES), University of Groningen, Groningen, The Netherlands.
W DouwengaDepartment of Molecular Neurobiology, Groningen Institute of Evolutionary Life Science (GELIFES), University of Groningen, Groningen, The Netherlands.
U L M EiselDepartment of Molecular Neurobiology, Groningen Institute of Evolutionary Life Science (GELIFES), University of Groningen, Groningen, The Netherlands.
E F J de VriesDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. e.f.j.de.vries@umcg.nl.

Funding

Stichting voor de Technische Wetenschappen 11650
6 · The paper itself

Abstract

purposeThe cuprizone (CPZ) mouse model for multiple sclerosis enables researchers to investigate the underlying mechanisms of demyelination and remyelination, as well as the effect of therapeutic interventions thereon. Over the last five decades, research revealed detailed analyses of brain tissue derived from CPZ-fed animals at different times of de- and re-myelination. Yet, longitudinal analysis of the effects of a CPZ diet on locomotor performance, myelination and neuroinflammation over a two-month recovery period are still unexplored. PROCEDURES: In this study, we comprehensively examined behavioural and neuropathological changes in the CPZ mouse model for a follow-up period of two months. We combined a longitudinal PET imaging approach with a more traditional approach of obtaining tissue and performing immunohistochemistry and behavioural tests in cohorts.

resultsWe found that mice fed with 0.2% CPZ for 5 weeks showed transient motor deficits which recovered quickly after cuprizone was removed from the diet. Similarly, remyelination also promptly restored myelin content after CPZ toxic insult, as seen by PET imaging with [

conclusionsTaken together, this longitudinal study reveals that a five-week CPZ diet leads to transient motor and loss of myelin, which recover quickly after CPZ is removed. In contrast, neuroinflammation persists for at least two months following exposure and is mainly driven by astrocyte activation. The study warrants deeper analysis of the sustained neuroinflammatory response in the context of demyelinating diseases.

Indexed as

AstrocytesCentral Nervous SystemCuprizoneMotor ActivityMyelin SheathPositron-Emission TomographyAnimalsDemyelinating DiseasesDisease Models, AnimalLongitudinal StudiesMaleMiceMice, Inbred C57BLRemyelinationCuprizone[11C]MeDAS[11C]PK11195Balance beam testCuprizoneDemyelinationMOSS testNeuroinflammationPositron emission tomographyRemyelination

Identifiers

PMID41874822
PMCPMC13337915

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.